Induced Pluripotent Stem Cell (iPSC) - Global Strategic Business Report

Report
349 Pages
March 2024
Region: Global
Global Industry Analysts, Inc
ID: 4805485

The global market for Induced Pluripotent Stem Cell ((iPSC) is estimated at US$1.9 Billion in 2023 and is projected to reach US$3.1 Billion by 2030, growing at a CAGR of 6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

Market Growth: Understand the significant growth trajectory of the Vascular Cells segment, which is expected to reach US$1 Billion by 2030 with a CAGR of 6.5%. The Cardiac Cells segment is also set to grow at 7.1% CAGR over the next 8 years.
Regional Analysis: Gain insights into the U.S. market, estimated at $876.2 Million in 2023, and China, forecasted to grow at an impressive 7.7% CAGR to reach $116.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global Induced Pluripotent Stem Cell ((iPSC) Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Induced Pluripotent Stem Cell ((iPSC) Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global Induced Pluripotent Stem Cell ((iPSC) Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as Lonza Group Ltd., Evotec SE, FUJIFILM Holdings Corporation, and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 51 Featured):

Lonza Group Ltd.
Evotec SE
FUJIFILM Holdings Corporation
Abcam PLC
Horizon Discovery Ltd.
Cell Signaling Technology, Inc.
Cell Applications, Inc.
Invivogen
ALSTEM, LLC
Censo Biotechnologies Ltd.
Creative Bioarray
Creative Biolabs
Axol Bioscience Ltd.
ID Pharma Co., Ltd.
BlueRock Therapeutics, LLC

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
Stem Cells, Application Areas, and the Different Types: A Prelude
Applications of Stem Cells
Types of Stem Cells
Induced Pluripotent Stem Cell (iPSC): An Introduction
Production of iPSCs
First & Second Generation Mouse iPSCs
Human iPSCs
Key Properties of iPSCs
Transcription Factors Involved in Generation of iPSCs
Noteworthy Research & Application Areas for iPSCs
Induced Pluripotent Stem Cell ((iPSC) Market: Growth Prospects and Outlook
Drug Development Application to Witness Considerable Growth
Technical Breakthroughs, Advances & Clinical Trials to Spur Growth of iPSC Market
North America Dominates Global iPSC Market
Competition
Recent Market Activity
Select Innovation/Advancement
Induced Pluripotent Stem Cell (iPSC) - Global Key Competitors Percentage Market Share in 2023 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)

2. FOCUS ON SELECT PLAYERS

Axol Bioscience Ltd. (UK)
Cynata Therapeutics Limited (Australia)
Evotec SE (Germany)
Fate Therapeutics, Inc. (USA)
FUJIFILM Cellular Dynamics, Inc. (USA)
Ncardia (Belgium)
Pluricell Biotech (Brazil)
REPROCELL USA, Inc. (USA)
Sumitomo Dainippon Pharma Co., Ltd. (Japan)
Takara Bio, Inc. (Japan)
Thermo Fisher Scientific, Inc. (USA)
ViaCyte, Inc. (USA)

3. MARKET TRENDS & DRIVERS

Effective Research Programs Hold Key in Roll Out of Advanced iPSC Treatments
Induced Pluripotent Stem Cells: A Giant Leap in the Therapeutic Applications
Research Trends in Induced Pluripotent Stem Cell Space
Concerns Related to Embryonic Stem Cells Shift the Focus onto iPSCs
Regenerative Medicine: A Promising Application of iPSCs
Induced Pluripotent: A Potential Competitor to hESCs?
Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
Pluripotent Stem Cells Hold Significance for Cardiovascular Regenerative Medicine
Leading Causes of Mortality for Low-Income and High-Income Countries
Growing Importance of iPSCs in Personalized Drug Discovery
Persistent Advancements in Genetics Space and Subsequent Growth in Precision Medicine Augur Well for iPSCs Market
Global Precision Medicine Market (In US$ Billion) for the Years 2018, 2021 & 2024
Increasing Prevalence of Chronic Disorders Supports Growth of iPSCs Market
Worldwide Cancer Incidence: Number of New Cancer Cases Diagnosed for 2012, 2018 & 2040
Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
Rising Diabetes Prevalence Presents Opportunity for iPSCs Market: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for iPSCs Market
Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
Growth in Number of Genomics Projects Propels Market Growth
Genomic Initiatives in Select Countries
Launch of Numerous iPSCs-Related Clinical Trials Set to Benefit Market Growth
iPSCs-based Clinical Trial for Heart Diseases
Induced Pluripotent Stem Cells for Stroke Treatment
‘Off-the-shelf’ Stem Cell Treatment for Cancer Enters Clinical Trial
iPSCs for Hematological Disorders
Market Benefits from Growing Funding for iPSCs-Related R&D Initiatives
Human iPSC Banks: A Review of Emerging Opportunities and Drawbacks
Human iPSC Banks Worldwide: An Overview
Cell Sources and Reprogramming Methods Used by Select iPSC Banks
Innovations, Research Studies & Advancements in iPSCs
Key iPSC Research Breakthroughs for Regenerative Medicine
Researchers Develop Novel Oncogene-Free and Virus-Free iPSC Production Method
Scientists Study Concerns of Genetic Mutations in iPSCs
iPSCs Hold Tremendous Potential in Transforming Research Efforts
Researchers Highlight Potential Use of iPSCs for Developing Novel Cancer Vaccines
Scientists Use Machine Learning to Improve Reliability of iPSC Self-Organization
STEMCELL Technologies Unveils mTeSR™ Plus
Challenges and Risks Related to Pluripotent Stem Cells
A Glance at Issues Related to Reprogramming of Adult Cells to iPSCs
A Note on Legal, Social and Ethical Considerations with iPSCs

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Vascular Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 2: World 7-Year Perspective for Vascular Cells by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 3: World Recent Past, Current & Future Analysis for Cardiac Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 4: World 7-Year Perspective for Cardiac Cells by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 5: World Recent Past, Current & Future Analysis for Neuronal Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 6: World 7-Year Perspective for Neuronal Cells by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 7: World Recent Past, Current & Future Analysis for Liver Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 8: World 7-Year Perspective for Liver Cells by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 9: World Recent Past, Current & Future Analysis for Immune Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 10: World 7-Year Perspective for Immune Cells by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 11: World Recent Past, Current & Future Analysis for Other Cell Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 12: World 7-Year Perspective for Other Cell Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 13: World Recent Past, Current & Future Analysis for Cellular Reprogramming by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 14: World 7-Year Perspective for Cellular Reprogramming by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 15: World Recent Past, Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 16: World 7-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 17: World Recent Past, Current & Future Analysis for Cell Differentiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 18: World 7-Year Perspective for Cell Differentiation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 19: World Recent Past, Current & Future Analysis for Cell Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 20: World 7-Year Perspective for Cell Analysis by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 21: World Recent Past, Current & Future Analysis for Cellular Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 22: World 7-Year Perspective for Cellular Engineering by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 23: World Recent Past, Current & Future Analysis for Other Research Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 24: World 7-Year Perspective for Other Research Methods by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 25: World Recent Past, Current & Future Analysis for Drug Development & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 26: World 7-Year Perspective for Drug Development & Toxicology Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 27: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 28: World 7-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 29: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 30: World 7-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 32: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
Table 33: World Induced Pluripotent Stem Cell (iPSC) Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030
Table 34: World Recent Past, Current & Future Analysis for Induced Pluripotent Stem Cell (iPSC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 35: World 7-Year Perspective for Induced Pluripotent Stem Cell (iPSC) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030

III. MARKET ANALYSIS

UNITED STATES

Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)

CANADA

JAPAN

Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)

CHINA

Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)

EUROPE

Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)

FRANCE

Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)

GERMANY

Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)

ITALY

UNITED KINGDOM

Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)

REST OF EUROPE

ASIA-PACIFIC

Induced Pluripotent Stem Cell (iPSC) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)

REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Lonza Group Ltd.
Evotec SE
FUJIFILM Holdings Corporation
Abcam PLC
Horizon Discovery Ltd.
Cell Signaling Technology, Inc.
Cell Applications, Inc.
Invivogen
ALSTEM, LLC
Censo Biotechnologies Ltd.
Creative Bioarray
Creative Biolabs
Axol Bioscience Ltd.
ID Pharma Co., Ltd.
BlueRock Therapeutics, LLC

Table Information

Report Attribute	Details
No. of Pages	349
Published	March 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 1.9 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.1 Billion
Compound Annual Growth Rate	6.0%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4763EUR$4,950USD£4,030GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€9049EUR$9,405USD£7,656GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€14288EUR$14,850USD£12,089GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 51 Featured):

MarketGlass Platform

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Induced Pluripotent Stem Cell (iPSC) Global Market Report 2024

Induced Pluripotent Stem Cells: Global Markets 2023-2028

Global Induced Pluripotent Stem Cells Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028

Global Induced Pluripotent Stem Cells Production Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

Induced Pluripotent Stem Cells - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029